These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 10894047

  • 21. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
    Sanders KE, Ha CS, Cortes-Franco JE, Koller CA, Kantarjian HM, Cox JD.
    Cancer; 2004 May 15; 100(10):2176-80. PubMed ID: 15139061
    [Abstract] [Full Text] [Related]

  • 22. Outcome of adult acute lymphoblastic leukemia: a single center experience.
    Usman M, Burney I, Nasim A, Adil SN, Salam A, Siddiqui T, Khurshid M.
    J Pak Med Assoc; 2003 Sep 15; 53(9):384-8. PubMed ID: 14620310
    [Abstract] [Full Text] [Related]

  • 23. FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia.
    Specchia G, Pastore D, Carluccio P, Liso A, Mestice A, Rizzi R, Ciuffreda L, Pietrantuono G, Liso V.
    Ann Hematol; 2005 Nov 15; 84(12):792-5. PubMed ID: 16047203
    [Abstract] [Full Text] [Related]

  • 24. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D, Chelghoum Y, Le QH, Elhamri M, Michallet M, Thomas X.
    Ann Hematol; 2003 Nov 15; 82(11):684-90. PubMed ID: 12928754
    [Abstract] [Full Text] [Related]

  • 25. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ.
    Cancer; 2004 Dec 15; 101(12):2788-801. PubMed ID: 15481055
    [Abstract] [Full Text] [Related]

  • 26. Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program: adult acute lymphoblastic leukemia-94 trial.
    Le QH, Thomas X, Ecochard R, Iwaz J, Lhéritier V, Michallet M, Fiere D.
    Cancer; 2007 May 15; 109(10):2058-67. PubMed ID: 17407135
    [Abstract] [Full Text] [Related]

  • 27. Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials.
    Tavernier E, Le QH, de Botton S, Dhédin N, Bulabois CE, Reman O, Vey N, Lhéritier V, Dombret H, Thomas X.
    Cancer; 2007 Dec 15; 110(12):2747-55. PubMed ID: 17963265
    [Abstract] [Full Text] [Related]

  • 28. [Clinical study of Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Bao L, Jiang B, Huang XJ, Wang DB, Qiu JY, Lu XJ, Chen H, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan 15; 26(1):31-4. PubMed ID: 15946506
    [Abstract] [Full Text] [Related]

  • 29. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B, Reiter A, Landmann E, Lang P, Lassay L, Dickerhoff R, Lakomek M, Henze G, von Stackelberg A.
    J Clin Oncol; 2009 Jul 10; 27(20):3363-9. PubMed ID: 19433688
    [Abstract] [Full Text] [Related]

  • 30. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
    Einsiedel HG, von Stackelberg A, Hartmann R, Fengler R, Schrappe M, Janka-Schaub G, Mann G, Hählen K, Göbel U, Klingebiel T, Ludwig WD, Henze G.
    J Clin Oncol; 2005 Nov 01; 23(31):7942-50. PubMed ID: 16258094
    [Abstract] [Full Text] [Related]

  • 31. [Survival in adults with acute lymphoblastic leukaemia].
    Tangen JM, Fløisand Y, Haukås E, Naess IA, Skjelbakken T, Stapnes C, Tjønnfjord GE.
    Tidsskr Nor Laegeforen; 2010 Sep 09; 130(17):1710-3. PubMed ID: 20835280
    [Abstract] [Full Text] [Related]

  • 32. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
    Suzuki N, Yumura-Yagi K, Yoshida M, Hara J, Nishimura S, Kudoh T, Tawa A, Usami I, Tanizawa A, Hori H, Ito Y, Miyaji R, Oda M, Kato K, Hamamoto K, Osugi Y, Hashii Y, Nakahata T, Horibe K, Japan Association of Childhood Leukemia Study (JACLS).
    Pediatr Blood Cancer; 2010 Jan 09; 54(1):71-8. PubMed ID: 19813250
    [Abstract] [Full Text] [Related]

  • 33. [Therapeutic results of acute lymphoblastic leukemia of children in Tunisia (181 cases)].
    Meddeb B, Ben Abdallah M, Hafsia R, Ben Othman T, Hafsia A, Mtimet B, Boussen M.
    Tunis Med; 1988 Jan 09; 66(8-9):593-7. PubMed ID: 3206555
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of elderly patients with acute lymphoblastic leukemia--evidence for a benefit of imatinib in BCR-ABL positive patients.
    Brandwein JM, Gupta V, Wells RA, Schuh AC, Schimmer AD, Lipton JH, Messner HA, Yi QL, Chun K, Kamel-Reid S, Minden MD.
    Leuk Res; 2005 Dec 09; 29(12):1381-6. PubMed ID: 15927253
    [Abstract] [Full Text] [Related]

  • 35. Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience.
    Robak T, Szmigielska-Kapłon A, Wrzesień-Kuś A, Wierzbowska A, Skotnicki AB, Piatkowska-Jakubas B, Kuliczkowski K, Mazur G, Zduńczyk A, Stella-Hołowiecka B, Hołowiecki J, Dwilewicz-Trojaczek J, Madry K, Dmoszyńska A, Cioch M.
    Ann Hematol; 2004 Apr 09; 83(4):225-31. PubMed ID: 14648030
    [Abstract] [Full Text] [Related]

  • 36. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol.
    Bajel A, George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M.
    Pediatr Blood Cancer; 2008 Nov 09; 51(5):621-5. PubMed ID: 18688848
    [Abstract] [Full Text] [Related]

  • 37. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.
    Ribera JM, Oriol A, Bethencourt C, Parody R, Hernández-Rivas JM, Moreno MJ, del Potro E, Torm M, Rivas C, Besalduch J, Sanz MA, Ortega JJ, PETHEMA Group, Spain.
    Haematologica; 2005 Oct 09; 90(10):1346-56. PubMed ID: 16219571
    [Abstract] [Full Text] [Related]

  • 38. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L, Labopin M, Gratwohl A, Gluckman E, Frassoni F, Beelen DW, Willemze R, Montserrat E, Blaise D, Atienza AI, Sierra J, Santos M, Gorin NC, Rocha V, Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Haematologica; 2008 Jun 09; 93(6):834-41. PubMed ID: 18469352
    [Abstract] [Full Text] [Related]

  • 39. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.
    Biol Blood Marrow Transplant; 2008 Jun 09; 14(6):685-92. PubMed ID: 18489994
    [Abstract] [Full Text] [Related]

  • 40. Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia.
    Karbasian-Esfahani M, Wiernik PH, Novik Y, Paietta E, Dutcher JP.
    Cancer; 2004 Sep 15; 101(6):1414-9. PubMed ID: 15368329
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.